During the past decade, Allergy Asthma Research Institute conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 10 clinical trials were completed, i.e. on average, 111.1% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Allergy Asthma Research Institute" #1 sponsor was "Meda Pharmaceuticals" with 5 trials, followed by "Sunovion" with 4 trials sponsored, "Bellus Health Inc" with 2 trials sponsored, "Société des Produits Nestlé (SPN)" with 2 trials sponsored and "Allergy Therapeutics" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Allergy Asthma Research Institute" #1 collaborator was "Allied Research International" with 1 trials as a collaborator, "Global BioClinical" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Allergy Asthma Research Institute" are "Seasonal Allergic Rhinitis" (7 trials), "Asthma" (5 trials), "Perennial Allergic Rhinitis" (2 trials), "Refractory Chronic Cough" (2 trials) and "Allergic Conjunctivitis" (1 trials). Many other conditions were trialed in "Allergy Asthma Research Institute" in a lesser frequency.

Most popular intervention types in "Allergy Asthma Research Institute" are "Drug" (18 trials), "Other" (2 trials), "Biological" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "BLU-5937" (2 trials), "Ciclesonide nasal aerosol 37 mcg" (2 trials), "Control extensively hydrolyzed formula" (2 trials) and "Placebo nasal spray" (2 trials). Other intervention names were less common.

The vast majority of trials in "Allergy Asthma Research Institute" are 21 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Allergy Asthma Research Institute". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Allergy Asthma Research Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Allergy Asthma Research Institute, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".